TickerFactsScreenerDevelopers

Ultragenyx Pharmaceutical Inc. (RARE) — Net Income

Annual figures by fiscal year, from SEC filings.

2012: -$16.33M2013: -$35.07M2014: -$59.80M2015: -$145.62M2016: -$245.87M2017: -$302.14M2018: -$197.61M2019: -$402.73M2020: -$186.57M2021: -$454.02M2022: -$707.42M2023: -$607.00M2024: -$569.00M2025: -$575.00M-$575.00M
2012Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$575.00M-1.1%
2024-$569.00M+6.3%
2023-$607.00M+14.2%
2022-$707.42M-55.8%
2021-$454.02M-143.4%
2020-$186.57M+53.7%
2019-$402.73M-103.8%
2018-$197.61M+34.6%
2017-$302.14M-22.9%
2016-$245.87M-68.8%
2015-$145.62M-143.5%
2014-$59.80M-70.5%
2013-$35.07M-114.7%
2012-$16.33M—